Key result
The PRAIS-2 risk model demonstrated excellent discrimination for 30-day mortality after paediatric cardiac surgery, with an AUC of 0.88 in the 2015-2019 validation cohort.
Why the study?
The authors sought to perform an independent temporal external validation of the PRAIS-2 model to predict 30-day mortality in patients undergoing paediatric cardiac surgery.
Does the PRAIS-2 model accurately predict 30-day mortality in pediatric patients undergoing cardiac surgery?
Cohort (n=2,549)
No
Does the PRAIS-2 model accurately predict 30-day mortality in pediatric patients undergoing cardiac surgery?
The PRAIS-2 model demonstrates excellent discrimination and good contemporary calibration for predicting 30-day mortality after pediatric cardiac surgery, supporting its wider clinical adoption.
Answers are grounded in this paper and cite their sources.
May support risk stratification in pediatric cardiac surgery; leaves open prospective trials of clinical impact.
OBJECTIVE: Independent temporal external validation of the improving partial risk adjustment in surgery model (PRAIS-2) to predict 30-day mortality in patients undergoing paediatric cardiac surgery. DESIGN: Retrospective analysis of prospectively collected data. SETTING: Paediatric cardiac surgery. INTERVENTION: PRAIS-2 validation was carried out using a two temporally different single centre (Bristol, UK) cohorts: Cohort 1 surgery undertaken from April 2004 to March 2009 and Cohort 2 from April 2015 to July 2019. For each subject PRAIS-2 score was calculated according to the original formula. PARTICIPANTS: A total of 1352 (2004-2009) and 1197 (2015-2019) paediatric cardiac surgical procedures were included in the Cohort 1 and Cohort 2, respectively (median age at the procedure 6.3 and 7.1 months). PRIMARY AND SECONDARY OUTCOME MEASURES: PRAIS-2 performance was assessed in terms of discrimination by means of ROC (receiver operating characteristic) curve analysis and calibration by using the calibration belt method. RESULTS: PRAIS-2 score showed excellent discrimination for both cohorts (AUC 0.72 (95%CI: 0.65 to 0.80) and 0.88 (95%CI: 0.82 to 0.93), respectively). While PRAIS-2 was only marginally calibrated in Cohort 1, with a tendency to underestimate risk in lowrisk and overestimate risk in high risk procedures (P-value = 0.033), validation in Cohort 2 showed good calibration with the 95% confidence belt containing the bisector for predicted mortality (P-value = 0.143). We also observed good prediction accuracy in the non-elective procedures (N = 483;AUC 0.78 (95%CI 0.68 to 0.87); Calibration belt containing the bisector (P-value=0.589). CONCLUSIONS: In a single centre UK-based cohort, PRAIS-2 showed excellent discrimination and calibration in predicting 30-day mortality in paediatric cardiac surgery including in those undergoing non-elective procedures. Our results support a wider adoption of PRAIS-2 score in the clinical practice.
No takes yet. Share an insight, caveat, or question.
Cocomello et al. (2020) conducted a cohort in Paediatric cardiac surgery (n=2,549). PRAIS-2 risk model was evaluated on 30-day mortality (AUC 0.88, 95% CI 0.82 to 0.93). The PRAIS-2 risk model demonstrated excellent discrimination for 30-day mortality after paediatric cardiac surgery, with an AUC of 0.88 in the 2015-2019 validation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: